nevirapine

Product NDC: 69097-233
11-digit product format: 690970233
Labeler code: 69097
Product ID: 69097-233_d8c3e274-100e-4526-84a2-ef541b415d4e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: nevirapine
Dosage form: SUSPENSION
Route: ORAL
Labeler: Cipla USA Inc.
Application: ANDA207684
Marketing category: ANDA
Marketing start: 2017-08-03
Marketing end: 0000-00-00
Substance: NEVIRAPINE HEMIHYDRATE
Active strength: 50 mg/5mL
Pharmacologic classes: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	69097-233		D	Discontinued by firm	2026-08-17
excluded package	package	69097-233	69097-233-44	D	Discontinued by firm	2026-08-17
excluded package	package	69097-233	69097-233-46	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 63 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69097-233-46	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	69097-233-44	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69097-233-46	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	69097-233-44	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69097-233-46	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	69097-233-44	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69097-233-46	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	69097-233-44	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69097-233-46	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	69097-233-44	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69097-233-46	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	69097-233-44	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69097-233-46	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	69097-233-44	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69097-233-46	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	69097-233-44	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69097-233-46	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	69097-233-44	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69097-233-46	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	69097-233-44	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69097-233-46	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	69097-233-44	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69097-233-46	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	69097-233-44	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69097-233-46	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	69097-233-44	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69097-233-46	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	69097-233-44	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69097-233-46	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	69097-233-44	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	69097-233-46	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	69097-233-44	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	69097-233-46	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	69097-233-44	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	69097-233-46	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	69097-233-44	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	69097-233-46	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	69097-233-44	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	69097-233-46	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	69097-233-44	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A207684-001	NEVIRAPINE	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA		2017-08-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A207684-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A207684-001	NEVIRAPINE	50MG/5ML	SUSPENSION / ORAL	AA	2017-08-03	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A207684-001	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A207684-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207684-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207684-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207684-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207684-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207684-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207684-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207684-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207684-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207684-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207684-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207684-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207684-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207684-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207684-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A207684-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A207684-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A207684-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A207684-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A207684-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A207684-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A207684-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A207684-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A207684-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A207684-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A207684-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A207684-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A207684-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A207684-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A207684-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A207684-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A207684-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A207684-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A207684-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A207684-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A207684-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A207684-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A207684-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A207684-001	AA	1	`e64feba35796…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
69097-233-44	2025-12-22	These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension, for oral use Initial U.S. Approval: 1996
69097-233-46	2025-12-22	These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension, for oral use Initial U.S. Approval: 1996
69097-233-44	2020-01-31	These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension, for oral use Initial U.S. Approval: 1996
69097-233-46	2020-01-31	These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension, for oral use Initial U.S. Approval: 1996

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
69097-233	NEVIRAPINE SUSPENSION [CIPLA USA INC.]	6	Legacy NDC	20181218_d1e92221-5e02-4ed9-b53e-d83bbbd07944.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
B7XF2TD73C	NEVIRAPINE HEMIHYDRATE	220988-26-1	NEVIRAPINE HEMIHYDRATE
99DK7FVK1H	NEVIRAPINE	129618-40-2	nevirapine